2024
Critical view on antimicrobial, antibiofilm and cytotoxic activities of quinazolin-4(3H)-one derived schiff bases and their Cu(II) complexes
PINDJAKOVA, Dominika, Sarka MASCARETTI, Jana HRICOVINIOVA, Jan HOSEK, Jana GREGOROVÁ et. al.Základní údaje
Originální název
Critical view on antimicrobial, antibiofilm and cytotoxic activities of quinazolin-4(3H)-one derived schiff bases and their Cu(II) complexes
Autoři
PINDJAKOVA, Dominika, Sarka MASCARETTI (203 Česká republika), Jana HRICOVINIOVA, Jan HOSEK (203 Česká republika), Jana GREGOROVÁ (203 Česká republika, domácí), Jiří KOS (203 Česká republika, domácí), Alois CIZEK (203 Česká republika), Zuzana HRICOVINIOVA a Josef JAMPILEK (203 Česká republika)
Vydání
Heliyon, OXFORD, ELSEVIER, 2024, 2405-8440
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10608 Biochemistry and molecular biology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.000 v roce 2022
Organizační jednotka
Lékařská fakulta
UT WoS
001227020400001
Klíčová slova anglicky
Quinazolinones; Schiff bases; Cu(II) complexes; Antibacterial activity; Antibiofilm effect; Cytotoxicity
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 2. 7. 2024 09:36, Mgr. Tereza Miškechová
Anotace
V originále
A series of nine 2,3-disubstituted-quinazolin-4(3 H )-one derived Schiff bases and their three Cu(II) complexes was prepared and tested for their antimicrobial activities against reference strains Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 and resistant clinical isolates of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecalis (VRE). All the substances were tested in vitro against Mycobacterium tuberculosis H 37 Ra ATCC 25177, M. kansasii DSM 44162 and M. smegmatis ATCC 700084. While anti-enterococcal and antimycobacterial activities were insignificant, 3-[( E )-(2-hydroxy-5-nitrobenzylidene)amino]-2-(2- hydroxy-5-nitrophenyl)-2,3-dihydroquinazolin-4(1 H )-one ( SB3 ) and its Cu(II) complex ( SB3 -Cu ) demonstrated bacteriostatic antistaphylococcal activity. In addition, both compounds, as well as the other two prepared complexes, showed antibiofilm activity, which resulted in a reduction of biofilm formation and eradication of mature S. aureus biofilm by 80% even at concentrations lower than the values of their minimum inhibitory concentrations. In addition, the compounds were tested for their cytotoxic effect on the human monocytic leukemia cell line THP-1. The antileukemic efficiency was improved by the preparation of Cu(II) complexes from the corresponding non-chelated Schiff base ligands.
Návaznosti
ROZV/28/LF10/2020, interní kód MU |
|